Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Abemaciclib for recurrent gynecologic cancers, including endometrial, fallopian tube, ovarian, and pr…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone [Phase 2]
Phase 2 study of Onapristone ER alone or with Anastrozole in progesterone-responsive gynecologic cancers has completed. Results were posted …
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating body surface area-based dosing versus concentration-based dosing of cisplatin for HIPEC in women with advanced ovar…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum [Phase 2]
Phase 2 clinical trial update for I-131 Omburtamab in Desmoplastic Small Round Cell Tumor and other peritoneal cancers; the study is current…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating MV-NIS infected mesenchymal stem cells for recurrent ovarian, primary peritoneal, or fallopian tube cancer. Res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2025-07-14FDA Approved: ELAHERE — Supplemental Application (ImmunoGen, Inc.)
The FDA approved a supplemental application for ELAHERE (mirvetuximab soravtansine) from ImmunoGen, Inc., updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial comparing MORAb-202 to investigator's choice chemotherapy in women with platinum-resistant high-grade serous ovarian cancer an…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 study evaluating personalized timing of interval debulking surgery for advanced ovarian cancer. The trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update describing a study on personalized timing of interval debulking surgery for advanced ovarian cancer; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.
-
CLINICAL_TRIALS research · 2025-06-30Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase II clinical study evaluating Utidelone Capsule (UTD2) in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer; th…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Surgery for Relapsed Ovarian Cancer in Precision [Phase 1, Phase 2]
A precision medicine-guided surgical approach for relapsed ovarian, fallopian tube, and primary peritoneal cancers is being explored in Phas…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 4]
A Phase 4 interventional trial evaluating Avastin (bevacizumab) in advanced or metastatic ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial update reports results for maintenance therapy with rucaparib and nivolumab in ovarian cancer patients who responded to fron…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating ZEN003694 in combination with Talazoparib for recurrent ovarian cancer and related gynecologic cancer…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating ONC-201 in combination with weekly paclitaxel for platinum-refractory or resistant ovarian cancer; current…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This document reports the termination of a Phase 1/2 trial of AVB-S6-500 in combination with durvalumab for platinum-resistant or recurrent …
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer [Phase 2]
Phase 2 European trial evaluating enhanced DNA repair inhibition in ovarian cancer has completed enrollment and posted results. The study al…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the safety of KAND567 in combination with carboplatin in w…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors [NA]
This clinical trial update describes MT027 cell injection being studied in patients with advanced primary or secondary peritoneal tumors. Th…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors [Phase 1]
Phase 1 study evaluating intra-tumoral injections of vvDD-hIL2-2-RG-1 for metastatic gastric, esophageal, liver, colorectal, and peritoneal …
-
CLINICAL_TRIALS withdrawal · 2025-06-03Clinical Trial Update: Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Withdrawal of a Phase 1/2 trial evaluating adding ASTX660 (tolinapant) to paclitaxel with or without bevacizumab in patients with recurrent …
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer [Phase 2]
An ongoing Phase 2 study evaluating pembrolizumab in combination with chemotherapy for platinum-sensitive recurrent low-grade serous ovarian…